Biotech The Role of the Ames Test in Predicting the Genotoxicity of Impurity Compounds in Drugs Bymedicilon May 26, 2023
Biotech Ringene Biopharma’s pan-FGFR1-4 irreversible inhibitor RG002 tablets was approved for clinical use with the help of Medicilon one-stop preclinical biopharmaceutical R&D service platform Bymedicilon May 19, 2023
Biotech Medicilon Assists Xuanzhu Biopharmaceutical’s KM501, a First Double-antibody ADC Drug that Completely Knocks Out Fucose, has been Approved for Clinical Trials Bymedicilon May 18, 2023
Biotech Medicilon Helps iMBioRay’s CAR-raNK Cell Therapy Approved Clinical Trial Bymedicilon May 18, 2023
